Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Genomefrontier Therapeutics Tw Co., Ltd.

Clinical trials sponsored by Genomefrontier Therapeutics Tw Co., Ltd., explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

New 'Double Punch' CAR T-Cell therapy takes on tough blood cancers Results expected Mar 2027 (estimated)

Browse trials soon ready across all sponsors →

Trials to join now! 1 Not yet finished but already full! 1

15-Year watch begins for new cancer cell therapy

Knowledge-focused By invitation only

This study follows 18 people who previously received GF-CART01, a CAR T-cell therapy for certain blood cancers like lymphoma. Researchers will track side effects and how long the modified cells last in the body for up to 15 years. The goal is to ensure the treatment remains safe …

Sponsor: GenomeFrontier Therapeutics TW Co., Ltd. • Aim: Knowledge-focused

Last updated Jun 27, 2026 13:06 UTC